Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.23.1
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Product sales, net $ 4,148 $ 4,447
Cost of goods sold 2,366 3,291
Gross profit 1,782 1,156
Operating expenses:    
Research and development 35 121
Selling, general and administrative 2,156 2,550
Benefit from reversal of accrued payroll taxes (Note 11) (6,171) 0
 Total operating expenses (3,980) 2,671
Operating income (loss) 5,762 (1,515)
Interest expense, net 56 702
Net income (loss) $ 5,706 $ (2,217)
Weighted average common shares outstanding, basic (in shares) 152,104 116,834
Weighted average common shares outstanding, diluted (in shares) 152,104 116,834
Net income (loss) per common share, basic (in USD per share) $ 0.04 $ (0.02)
Net income (loss) per common share, diluted (in USD per share) $ 0.04 $ (0.02)
Revenue, product and service [Extensible List] Product [Member] Product [Member]